News & Events
A review of MI-ONCOSEQ clinical sequencing program at Michigan Medicine
Immunohistochemical evaluation of markers suggest a role for prospective FH IHC to screen cutaneous leiomyoma patients for HLRCC.
New research suggests a novel strategy to target a genetic anomaly that occurs in half of all prostate cancers.
Dr. Chinnaiyan's research career featured in an article in the journal, Cancer
Several MCTP members were recent award recipients
MCTP wins Occupational Safety & Environmental Health Safety First Recognition Award.
MCTP members were recipients of several awards.
Discovery of a functional KRAS-AGO2 interaction may have implications for novel therapeutic strategy for KRAS-driven cancers.
AACR leadership and members including Dr. Arul Chinnaiyan meet with FDA officials and Vice President's senior staff.
MCTP researchers and collaborators have published the results from the first 102 pediatric patients enrolled in the PEDS-ONCOSEQ clinical sequencing study.
New study is the first comprehensive molecular landscape of metastatic castrate-resistant prostate cancer.
MLL-menin inhibitor disrupts AR-MLL complex interaction that results in blocking AR signaling and inhibiting the growth of castration-resistant tumors.
MCTP researchers, Nalla Palanisamy and Rohit Mehra, were featured in Advanced Cell Diagnostics' "Researcher in the Spotlight" newsletter where they discussed their work.
MCTP researchers analyzed the global landscape of a portion of the genome that has not been previously well-explored – long non-coding RNAs (lncRNAs).
Drs. Arul Chinnaiyan and Shaomeng Wang were named 2014 National Academy of Inventors (NAI) Fellows.
BVSK Chakravarthi's (mentor- Soory Varambally) abstract, submitted to the Cancer Research Committee, was chosen as one of the top five abstracts for the 2014 Cancer Center Fall Research Symposium.
Dr. Arul Chinnaiyan joins Dr. Drew for a discussion about Prostate Cancer Research.
Dr. Irfan Asangani, PhD, Research Investigator at MCTP, has received the highly competitive and prestigious NCI Pathway to Independence Award (K99/R00).
John Prensner was the recipient of Dean's Award for Research Excellence and Graduation with Distinction in Research Honors at Commencement Exercises on May 16, 2014.
New clinical assays on offer at MLabs’ GU Service Line.
Dr. Shaomeng Wang has been named the 2014 Distinguished University Innovator Award for his pioneering work in the field of drug discovery.
Researchers at MCTP have found a novel epigenetic approach to target castration resistant prostate cancer (CRPC).
Dr. Arul Chinnaiyan was one of five University of Michigan faculty to be elected to the American Academy of Arts and Sciences 2014 Class of Members.
Dr. Irfan Asangani was awarded a first prize for his poster entitled, "Therapeutic targeting of BET bromodomain proteins for castration-resistant prostate cancer" at the 2014 Prostate SPORE Retreat.
< newest 1 2 oldest >
MCTP Researchers have identified a type of mutation that develops after breast cancer patients take anti-estrogen therapies.